Bisnafide

N/A

Report date: 2022/05/12 17:20:46
NME

Base Information

Drug NameBisnafide
Drug Alias Name双奈法德Bisnafide mesylatebisnafide dimesylateBisnafide mesilateNSC-D-640430 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitorsRNA synthesis inhibitors
TargetsDNA
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A